Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure

Int J Cardiol. 2005 Apr 28;100(3):347-53. doi: 10.1016/j.ijcard.2004.05.030.

Abstract

Evidence suggests that vascular endothelium plays key role in the regulation of vascular tone, in the process of inflammation and in the thrombotic mechanisms. Recent studies indicate that it is an important component of the pathophysiological mechanisms of heart failure. Heart failure may induce endothelial dysfunction by different mechanisms, such as reduced synthesis and release of nitric oxide (NO), increased degradation of NO or by increased production of endothelin-1. In addition, endothelial dysfunction has been associated with the progression of heart failure. Alterations in neurotransmitters, hormones and also in physiological stimuli are present in heart failure and affect the vascular endothelium. Treatments with beneficial effects on endothelial dysfunction may also improve prognosis in patients with heart failure.

Publication types

  • Review

MeSH terms

  • Animals
  • Apoptosis / physiology
  • Carnitine / blood
  • Cell Adhesion Molecules / physiology
  • Endothelin-1 / physiology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiopathology*
  • Exercise / physiology
  • Heart Failure / drug therapy
  • Heart Failure / physiopathology
  • Humans
  • Inflammation / physiopathology*
  • Nitric Oxide / physiology
  • Tumor Necrosis Factor-alpha / analysis

Substances

  • Cell Adhesion Molecules
  • Endothelin-1
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide
  • Carnitine